Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
Complete resection is still the only curative treatment option in patients with soft tissue
sarcoma (STS). Patients with a non-resectable STS have a dismal prognosis even without
evidence of metastatic disease. The aim of this trial is to determine whether neoadjuvant
dose-intensive chemo-radiotherapy is a feasible and effective approach in patients with
non-resectable STS.